Featured Research

from universities, journals, and other organizations

Study Yields Insights Into Precancerous Condition

Date:
July 22, 2004
Source:
Beth Israel Deaconess Medical Center
Summary:
A study in the July 2004 issue of the medical journal Cancer Cell provides scientists with new insights into a rare genetic disorder known as Peutz-Jeghers Syndrome (PJS), and suggests that a class of drugs called mTOR inhibitors may be useful for the treatment of the condition, which has been linked to cancers of the gastrointestinal tract, lung, breast, uterus and ovaries.

BOSTON – A study in the July 2004 issue of the medical journal Cancer Cell provides scientists with new insights into a rare genetic disorder known as Peutz-Jeghers Syndrome (PJS), and suggests that a class of drugs called mTOR inhibitors may be useful for the treatment of the condition, which has been linked to cancers of the gastrointestinal tract, lung, breast, uterus and ovaries.

Related Articles


Caused by a mutation that inactivates the tumor suppressor gene, LKB1, PJS is characterized by the development of pigmented spots on the skin and the formation of gastrointestinal polyps.

"There is a 30 to 50 percent chance that these polyps will become malignant and lead to patients developing cancer," explains senior author Lewis Cantley, PhD, chief of the Division of Signal Transduction at Beth Israel Deaconess Medical Center (BIDMC) and a member of the Department of Systems Biology at Harvard Medical School.

Earlier research conducted by Cantley's laboratory on two other genetic conditions with symptoms similar to PJS – Cowden's syndrome and tuberous sclerosis – had found that the diseases involved defects in the regulation of a protein called mTOR (mammalian target of rapamycin). The researchers, therefore, decided to look for a link between LKB1 and mTOR.

As predicted, their study found that mouse cells lacking LKB1 and cells from PJS mouse polyps showed the activation of molecules known to be downstream of the mTOR protein.

"We knew that the drug rapamycin [commonly used to prevent newly transplanted organs from being rejected] could block mTOR," says Cantley. "These new results suggest that the use of mTOR inhibitors, including rapamycin analogs currently being tested in clinical trials for the treatment of cancers and tuberous sclerosis, may be useful for the treatment of polyps arising in PJS patients, and possibly in other tumors that result from the sporadic loss of LKB1."

Study co-authors include BIDMC researchers Reuben Shaw, PhD, Brendan Manning, PhD, and Monica Kosmatka, as well as Nabeel Bardeesy, PhD, Lyle Lopez, and Ronald DePinho, MD, of Dana-Farber Cancer Institute. This study was funded by grants from the National Institutes of Health.

###

Beth Israel Deaconess Medical Center is a major patient care, teaching and research affiliate of Harvard Medical School, and ranks third in NIH funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Care Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.harvard.edu.


Story Source:

The above story is based on materials provided by Beth Israel Deaconess Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Beth Israel Deaconess Medical Center. "Study Yields Insights Into Precancerous Condition." ScienceDaily. ScienceDaily, 22 July 2004. <www.sciencedaily.com/releases/2004/07/040721090406.htm>.
Beth Israel Deaconess Medical Center. (2004, July 22). Study Yields Insights Into Precancerous Condition. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2004/07/040721090406.htm
Beth Israel Deaconess Medical Center. "Study Yields Insights Into Precancerous Condition." ScienceDaily. www.sciencedaily.com/releases/2004/07/040721090406.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins